Skip to main content
Celularity Inc. (CELU)
NASDAQ: CELU · Real-Time Price · USD
1.210
+0.010 (0.83%)
At close: Mar 6, 2026, 4:00 PM EST
1.220
+0.010 (0.83%)
After-hours: Mar 6, 2026, 4:10 PM EST

Celularity Revenue

Celularity had revenue of $5.28M in the quarter ending September 30, 2025, a decrease of -43.16%. This brings the company's revenue in the last twelve months to $40.58M, down -15.81% year-over-year. In the year 2024, Celularity had annual revenue of $54.22M with 138.11% growth.

Revenue (ttm)
$40.58M
Revenue Growth
-15.81%
P/S Ratio
0.86
Revenue / Employee
$329,902
Employees
123
Market Cap
34.89M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202454.22M31.45M138.11%
Dec 31, 202322.77M4.80M26.68%
Dec 31, 202217.98M-3.36M-15.75%
Dec 31, 202121.34M7.06M49.43%
Dec 31, 202014.28M-6.87M-32.48%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Atara Biotherapeutics 151.93M
NovaBay Pharmaceuticals 10.30M
Pluri 1.34M
Lisata Therapeutics 1.07M
ABVC BioPharma 797.92K
Outlook Therapeutics 205.70K
Actinium Pharmaceuticals 90.00K
INmune Bio 50.00K
Revenue Rankings

CELU News

More News